Texas medtech firm invests in Biomimetic Innovations

RDJ advised Biomimetic Innovations Limited (“BMI”), a medical device company headquartered in Shannon on an equity investment of up to €8 million and associated licensing and distribution agreement with US company, Sanara MedTech Inc.

As part of the transaction, Sanara has secured an exclusive five-year US licence and distribution agreement with BMI for OsStic, a ground-breaking bio-adhesive bone void filter technology that allows doctors to stick broken bone tissue together following a fracture and help promote faster healing.

Biomimetic Innovations is a medical device company involved in design, development and manufacturing, that leads a consortium which is developing OsStic. The company is headquartered in Shannon, Co. Clare, Ireland, with offices in Memphis, Tennessee and Chamonix, France.

Based in Fort Worth, Texas, Sanara MedTech Inc. (Nasdaq: SMTI) is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare market.

The RDJ transaction team included Diarmaid Gavin and Alan Cronin (Corporate and Commercial).